New approaches for melanoma therapy combine measles virus targeted against melanoma-associated antigen (high molecular weight melanoma-associated antigen HMWMAA) and an insertion of the FCU1 gene (MV-FCU-1-α-HMWMAA) [140]. The gene discussed is CSPG4; the disease is melanoma.